Research

Dr. Walter Stadler, an oncologist at the University of Chicago and a member emeritus of the Kidney Cancer Association's Medical Steering Committee, spoke to Targeted Oncology about updates and changes in how kidney cancer is treated. Read an excerpt: TARGETED ONCOLOGY: How has the setting of kidney cancer changed over the last few years? STADLER: Well, I think that if I zoom…

Welcome to our new series where we take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo, MS, CGC, will show you what’s new and why it matters. Facebook Live I had a great discussion about the basics of clinical trials in…

Welcome to our new series where we take a look at what’s happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA’s Medical Director, Sallie McAdoo, MS, CGC, will show you what’s new and why it matters. This month, I’m focusing on some of the data for non-clear cell renal cell…

The 2021 KCA grants open for applications on March 1st, but before they do, we're looking back at the 2020 grant recipients. These innovative researchers are committed to advancing science and improving the way we treat and care for people with kidney cancer. Dr. William Kim is a physician-scientist and professor at the University of North Carolina-Chapel Hill and Dr.…

Welcome to our new series where we take a look at what's happening in kidney cancer each month! From treatments and clinical trials to genetic testing and government regulations, the KCA's Medical Director, Sallie McAdoo, MS, CGC, will show you what's new and why it matters. This month, there were two major announcements about kidney cancer treatments. Cabometyx plus Opdivo…

As the 30th anniversary of the Kidney Cancer Association comes to a close, we are taking stock of some of the milestones and initiatives this community has been a part of. Since it was founded in 1990, the KCA and the kidney cancer community have seen kidney cancer evolve from a disease with few treatment options and a limited future…

Dr. Tian Zhang is a medical oncologist at the Duke Cancer Institute. She is a 2019 KCA Young Investigator Award recipient and has contributed to the “Ask the Experts” resource about COVID-19 and kidney cancer. UPDATED information about Moderna's COVID-19 vaccine below. https://www.kidneycancer.org/covid-19-information-and-resources/ Nearly 10 months after the COVID-19 pandemic became a major public health threat, hopes for a vaccine…

In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research.Dr. Patrick Pilié is an Assistant Professor in the Department of Genitourinary Medical Oncology at MD Anderson Cancer Center in Houston, Texas. Dr. Pilié received the 2018 Kidney Cancer Association Young Investigator Award. We spoke to him…

In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research. Dr. Phillip Abbosh is an Assistant Professor of Urology at Albert Einstein Medical Center and researcher at Fox Chase Cancer Center in Philadelphia, Pennsylvania. He received the Kidney Cancer Association’s 2017 Young Investigator Award. We spoke to Dr. Phillip about his research project –…

In honor of our 30th anniversary, we’re catching up with former grant recipients to hear how their work has impacted kidney cancer care and research. Dr. Eliezer Van Allen is a medical oncologist at the Dana-Farber Cancer Institute and an Instructor in Medicine at the Harvard Medical School in Boston, Massachusetts. Dr. Van Allen received the 2013 ASCO Conquer Cancer Foundation…